Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
- Resource Type
- Article
- Authors
- De Velasco, Guillermo; Xie, Wanling; Donskov, Frede; Albiges, Laurence; Beuselinck, Benoit; Srinivas, Sandy; Agarwal, Neeraj; Lee, Jae Lyun; Brugarolas, James; Wood, Lori A.; Rha, Sun-young; Kollmannsberger, Christian; North, Scott; Kanesvaran, Ravindran; Rini, Brian I.; Broom, Reuben; Yamamoto, Haru; Kaymakcalan, Marina D.; Heng, Daniel Y.C.; Choueiri, Toni K.
- Source
- In Clinical Genitourinary Cancer June 2017 15(3):403-410
- Subject
- Language
- ISSN
- 1558-7673